Skip to main content

Table 1 Baseline data and histological findings of 118 patients with histologically proven non-alcoholic fatty liver disease (NAFLD) and 18 lean controls. Data is presented as mean (SD)

From: The non-invasive 13C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis

Variable

Lean Controls

n = 18

Simple Steatosis

n = 11

Borderline NASH

n = 47

Definite NASH

n = 53

NASH Cirrhosis

n = 7

Gender

     

    Male, n

11

7

31

36

5

    Female, n

7

4

16

17

2

Age, yr

44.0 (10)

51.0 (12)

50.5 (12)

49.5 (12)

59.0 (6)

BMI, kg/m 2

24.4 (2.3)

24.6 (4.6)

27.4 (7.2)

30.3 (6.3)a

31.1 (4.6)a

Serum ALT, U/l

26 (8)

41 (12)

67 (40)a

94 (64)aa

64 (30)a

Cholesterol, mg/dl

172 (12)

243 (39)

235 (47)

216 (49)

189 (48)

Triglycerides, mg/dl

136 (17)

142 (75)

239 (1172)

211 (127)

185 (118)

Impaired glucose tolerance, n

0

0

15

21

2

Diabetes mellitus Type 2, n

0

2

9

5

3

Fibrosis score, n

     

    F 0

-

9

11

2

-

    F 1

-

1

29

28

-

    F 2

-

1

3

10

-

    F 3

-

0

4

13

-

  1. ap < 0.01 vs. simple steatosis and lean controls by Dunn's post hoc test
  2. Abbreviations: ALT: alanine amino-transferase; BMI: body mass index; n: number of patients